Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01585311 · ClinicalTrials.gov registry record
Impact of Tachycardia on Outcome After Subarachnoid Hemorrhage (SAH)
A clinical trial, sponsored by Columbia University.
- Terminated
- Registry status
- 1,540
- Enrollment target
NCT01585311: Clinical Trial study, sponsored by Columbia University.
NCT01585311 is a clinical trial that was terminated before completion, run by Columbia University. The registered enrollment target is 1,540 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01585311 was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- 1,540 participants
- Enrollment target
Study Summary
The purpose of this retrospective study is to test the hypothesis that uncontrolled tachycardia serves as a risk factor for adverse cardiovascular events and poor outcome after Subarachnoid Hemorrhage (SAH).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,540 participants |
| Start Date | 2008-03 |
| Est. Completion | 2015-08 |
Why NCT01585311 stopped before completion
NCT01585311 is an observational study that tracks outcomes without assigning an intervention. Its 1,540 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01585311 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01585311 about?
NCT01585311 is a clinical study titled "Impact of Tachycardia on Outcome After Subarachnoid Hemorrhage (SAH)". The purpose of this retrospective study is to test the hypothesis that uncontrolled tachycardia serves as a risk factor for adverse cardiovascular events and poor outcome after Subarachnoid Hemorrhage (SAH).
What is the current status of trial NCT01585311?
This trial is currently terminated. The enrollment target is 1,540 participants. The study started on 2008-03. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT01585311?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03435796 · 1,541 participants · Phase 2
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- NCT06842875 · 1,536 participants · NA
Rhode Island - Statewide Postpartum Hypertension Remote Surveillance
- NCT06729775 · 1,546 participants · NA
Disentangling the Role of Culture, Life Stage, and Information Design to Facilitate Equity in Data Report Back
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia